drugset / Trial / NCT00755508

Efficacy and Safety of Ramelteon Combined With Gabapentin in Treating Patients With Insomnia

NCT00755508

Phase 2 Completed 378 enrolled Takeda
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine the efficacy and safety of ramelteon, once daily (QD), taken in combination with Gabapentin for treating insomnia.

Timeline

Start
2005-11
Primary completion
2006-09
Completion
2006-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Gabapentin Small molecule 400 mg Oral
Subject Gabapentin Small molecule 800 mg Oral
Subject Ramelteon Unknown 4 mg Oral
Subject Ramelteon Unknown 8 mg Oral